Life Sciences and Health Care

Shaping the evolution of an industry

The Life Sciences and Health Care industry group strives to support clients in addressing challenges that impact the industry. As the life sciences and health care industry continues to evolve, professionals from across Deloitte's global network engage with clients to develop innovative solutions to help them achieve their respective business missions and move closer to their vision for the future. Contact the LSHC group to learn more about Deloitte's global industry practice.

2014 Global health care sector outlook 2014 Global health care sector outlook
Shared challenges, shared opportunities.
   
2013 Global life sciences sector outlook 2014 Global life sciences sector outlook
Resilience and reinvention in a changing marketplace.
   
2013 Global life sciences sector outlook New businesses, new markets
The Financial Times and Deloitte bring you the 2013 Global Pharma/Biotech Conference, 3-4 December, London. Join the discussion with executives on the industry’s most pressing issues.
   
2013 Global life sciences sector outlook Transforming commercial models to address new health care realities
Imperative for biopharmaceutical companies to explore alternative commercial models to supplement traditional go-to-market strategies.
   
Impact of European Austerity on Pharmaceutical policy and pricing Impact of European austerity on pharmaceutical policy and pricing
A UK Deloitte Centre for Health solutions report that looks to understand the current European pharmaceutical market, the mechanisms for reducing pharmaceutical spending, the future of the pharmaceutical landscape, and the actions the pharmaceutical industry needs to take to survive current austerity.
   
Transformation beyond reform: A changing life sciences & health care industry Transformation beyond reform: A changing life sciences & health care industry
In conjunction with the Financial Times/Deloitte 2013 Health Care & Life Sciences conference, explore what lies ahead for global life sciences companies as they focus on the practicalities of dealing with the provisions and impacts of U.S. health care reform.
   
Health care reform and life sciences: Threat, opportunity or both? Health care reform and life sciences: Threat, opportunity or both?
New survey shows enhancing innovation, reducing costs, widening market access, and changing sales models are seen as major impacts on the life sciences industry from health care reforms around the world.